ARRIS Appoints Dolby Laboratories President & CEO Kevin Yeaman to Board of Directors

Dolby CEO Brings Proven Expertise in Licensing, Brand-Building & Technology Scaling to SupportARRIS' Next Phase of Growth ARRIS, a leader in advanced manufacturing for high-performance composites, today announced the appointment of Kevin Yeaman, President and CEO of Dolby Laboratories, to its Board of Directors. Yeaman brings deep expertise in introducing and scaling innovative technologies, pioneering […]

Industry-Leading Permanent Makeup Expert Ashley Swain Announces Advanced PMU Training Courses for Fall 2025

30-Year PMU Expert Ashley Swain Unveils Advanced Training Program for Experienced Professionals in Palm Beach Gardens, Florida. Ashley Swain Permanent Makeup & Medspa, a premier permanent makeup center serving Palm Beach County, today announced the launch of three advanced permanent makeup (PMU) training courses designed for experienced professionals seeking to elevate their skills. The comprehensive

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236

(NASDAQ:CERO), Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results SOUTH SAN FRANSCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to advance the next generation of

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236

CERo Therapeutics Doses Second Acute Myeloid Leukemia Patient with CER-1236 GlobeNewswire July 31, 2025 Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update on first patient pharmacokinetic results SOUTH SAN FRANSCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the

Freddie Mac Announces Second Quarter 2025 Financial Results

(Other OTC:FMCC),(OTC US:FMCC), MCLEAN, Va., July 31, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its Second Quarter 2025 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company's Form 10-Q and earnings press release, along with the Second Quarter 2025 financial results supplement

AestheticMatch Expands Luxury Concierge Platform, Connecting Patients to Screened Plastic Surgeons Nationwide

AestheticMatch, the Tribeca‑based digital concierge for cosmetic procedures, today announced the full national roll‑out of its free matching service that personally guides clients to qualified plastic surgeons who pass the company's rigorous screening process. Designed to cut through confusing online marketing and pay‑to‑play doctor listings, AestheticMatch delivers a white‑glove experience-from the first inquiry to post‑operative

Freddie Mac Announces Second Quarter 2025 Financial Results

Freddie Mac Announces Second Quarter 2025 Financial Results GlobeNewswire July 31, 2025 MCLEAN, Va., July 31, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its Second Quarter 2025 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company's Form 10-Q and earnings press release,

Vericel Reports Second Quarter 2025 Financial Results

(NasdaqGM:VCEL), Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million, with Adjusted EBITDA Margin Increase of More than 900 Basis Points to 21% Approximately 600 MACI Arthro Surgeons Trained

Scroll to Top